Nanoparticle System for Targeted Delivery of Antimicrobial Peptides in Cancer Treatment
Author Information
Author(s): Jiang Jingwen, Kaysar Kaderya, Pan Yanzhu, Xia Lijie, Li Jinyao, Barresi Antonello A.
Primary Institution: Xinjiang University, Urumqi, China
Hypothesis
The unique porous structure of ZIF-8 will shield CEC from proteolytic degradation within the tumor microenvironment and release the drug directly at the targeted area.
Conclusion
The CEC@ZIF-8 nano-drug delivery system significantly enhanced the anti-cervical cancer effect of CEC both in vivo and in vitro.
Supporting Evidence
- The CEC@ZIF-8 nano-delivery system had favorable biocompatibility and pH responsiveness.
- Flow cytometry showed that CEC@ZIF-8 NPs inhibited the growth of HeLa cells by arresting the cell cycle at the G0/G1 phase.
- Confocal imaging demonstrated greater intracellular accumulation and more potent cytotoxicity against cancer cells compared to free CEC.
- CEC@ZIF-8 NPs reduced the growth rate of xenograft tumors in mice without the systemic toxicity observed with cisplatin treatment.
Takeaway
Researchers created a special delivery system using tiny particles to help a cancer-fighting peptide reach tumors better and cause less harm to healthy cells.
Methodology
The study involved preparing a CEC nano-drug delivery system using ZIF-8, characterizing its properties, and evaluating its cytotoxicity and anti-cancer activity in vitro and in vivo.
Limitations
The study primarily focused on in vitro and in vivo models, which may not fully replicate human responses.
Participant Demographics
C57 male mice (6–8 weeks) were used for in vivo experiments.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website